Globus Medical Reports Fourth Quarter and Full Year 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Globus Medical (GMED) Tops Q4 EPS by 7c, FY Guidance Falls Short of Consensus
February 17, 2021 4:27 PM ESTGlobus Medical (NYSE: GMED) reported Q4 EPS of $0.58, $0.07 better than the analyst estimate of $0.51. Revenue for the quarter came in at $233.4 million versus the consensus estimate of $231.22 million.
GUIDANCE:
Globus Medical sees FY2021 EPS of $1.83, versus the consensus of $2.01. Globus... More
